Control of mitochondrial dynamics by the metabolic regulator dPGC1 limits Yorkie-induced oncogenic growth in Drosophila
PLOS Biology · 04.12.2025 · 23 (12) · e3003523
DOI: 10.1371/journal.pbio.3003523 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Biology, online erschienen am 04.12.2025. Verfasst von Wei Qi Guinevere Sew und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cellular and Molecular Medicine, University of Copenhagen, Copenhagen, Denmark. Hauptthemen laut MEDLINE: Drosophila Proteins, Mitochondrial Dynamics, Drosophila melanogaster, Nuclear Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 135 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Novo Nordisk Fonden, Neye Foundation, Grosserer Alfred Nielsen og Hustru’s Fond.
Abstract (Originalsprache)
Mitochondrial function and dynamics are essential for maintaining cellular homeostasis and overall health. Disruptions in these processes can contribute to various diseases, including cancer. The Hippo signaling pathway, a key regulator of tissue growth, plays a central role in cancer through its main effector YAP, known as Yki in Drosophila . In this model organism, Yki upregulation drives benign tissue overgrowth in imaginal discs. Our research demonstrates that the conserved metabolic regulator dPGC1 restricts Yki-driven tissue hyperplasia and helps maintain epithelial integrity in vivo . Combined Yki upregulation and dPGC1 depletion results in tumors characterized by enlarged mitochondria and the upregulation of genes promoting mitochondrial fusion, a condition that is both necessary and sufficient for Yki-driven oncogenic growth. We further demonstrate that mitochondrial enlargement is associated with increased levels of the cell cycle regulator Cyclin E, which plays a critical role in tumor development. These findings identify dPGC1 as a context-dependent tumor suppressor that coordinates mitochondrial dynamics and cell cycle regulation in response to oncogene activation, with implications for understanding cancer development in humans.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Cellular and Molecular Medicine, University of Copenhagen, Copenhagen, Denmark.
- Centre for Healthy Aging, Department of Cellular and Molecular Medicine, University of Copenhagen, Copenhagen, Denmark.
ORCID-Profile: Héctor Herranz
Förderung
- Novo Nordisk Fonden
- Neye Foundation
- Grosserer Alfred Nielsen og Hustru’s Fond
- Danmarks Frie Forskningsfond
- Grosserer Alfred Nielsen og Hustru’s fond
Zitieren
APA
Sew, W. Q. G., Molano-Fernández, M., Li, Z., Lange, A., Pérez de Ciriza, N., Rasmussen, L. J., & Herranz, H. (2025). Control of mitochondrial dynamics by the metabolic regulator dPGC1 limits Yorkie-induced oncogenic growth in Drosophila. PLOS Biology, 23(12), e3003523. https://doi.org/10.1371/journal.pbio.3003523
Vancouver
Sew WQG, Molano-Fernández M, Li Z, Lange A, Pérez de Ciriza N, Rasmussen LJ, et al. Control of mitochondrial dynamics by the metabolic regulator dPGC1 limits Yorkie-induced oncogenic growth in Drosophila. PLOS Biology. 2025;23(12):e3003523. doi:10.1371/journal.pbio.3003523
BibTeX
@article{Sew2025,
author = {Sew, Wei Qi Guinevere and Molano-Fernández, Maria and Li, Zhiquan and Lange, Artim and Pérez de Ciriza, Nahia and Rasmussen, Lene Juel and Herranz, Héctor},
title = {Control of mitochondrial dynamics by the metabolic regulator dPGC1 limits Yorkie-induced oncogenic growth in Drosophila},
journal = {PLOS Biology},
year = {2025},
volume = {23},
number = {12},
pages = {e3003523},
doi = {10.1371/journal.pbio.3003523}
}
EUVIMED